Biotechnology

Omeros

$18.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.41 (-2.13%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Omeros and other stocks, options, and ETFs commission-free!

About OMER

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA. The listed name for OMER is Omeros Corporation Common Stock.

CEO
Gregory A. Demopulos
Employees
258
Headquarters
Seattle, Washington
Founded
1994
Market Cap
1.11B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.08M
High Today
$19.70
Low Today
$18.71
Open Price
$18.90
Volume
1.09M
52 Week High
$25.46
52 Week Low
$8.50

Collections

OMER Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 1, After Hours

You May Also Like

CRTX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure